Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study (scientific article)

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

Q30665466

Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review

Q33594181

The validity of the Hospital Anxiety and Depression Scale. An updated literature review

Q34113060

Genome-wide association study identifies five new breast cancer susceptibility loci

Q34114293

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

Q34135443

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

Q34193483

Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing.

Q35016127

Beliefs about weight and breast cancer: an interview study with high risk women following a 12 month weight loss intervention

Q35041396

Interest in genomic SNP testing for prostate cancer risk: a pilot survey.

Q35403712

Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer

Q35832375

The genetic epidemiology of breast cancer genes

Q35959353

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Q35996692

Psychological impact of genetic testing for cancer susceptibility: an update of the literature

Q36153016

Prediction of breast cancer risk based on profiling with common genetic variants

Q36583004

"Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer

Q36595655

Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry

Q36619329

Translational Genomic Research: Protocol Development and Initial Outcomes following SNP Testing for Colon Cancer Risk

Q36738056

Risk reduction and health promotion behaviors following genetic testing for adult-onset disorders

Q36879101

Behavioral and psychosocial responses to genomic testing for colorectal cancer risk

Q37060585

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

Q37090813

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families

Q37131918

Genetic counseling as a tool for type 2 diabetes prevention: a genetic counseling framework for common polygenetic disorders

Q37312886

Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab

Q37410693

Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk

Q37711233

Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors

Q37963750

Inherited genetic susceptibility to breast cancer: the beginning of the end or the end of the beginning?

Q38131236

Impact of Event Scale: A Measure of Subjective Stress

Q39513124

Factors influencing intention to undergo whole genome screening in future healthcare: a single-blind parallel-group randomised trial.

Q39560593

Psychiatric genetic counselling for parents of individuals affected with psychotic disorders: a pilot study

Q40097715

Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation

Q46621012

Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families

Q46735021

BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample

Q47343483

Application of the protection motivation theory to genetic testing for breast cancer risk.

Q48614853

Predictors of breast cancer screening behavior in women with a strong family history of the disease.

Q50699640

Validation of a decision regret scale.

Q51019738

Psychological impact of genetic testing in women from high-risk breast cancer families.

Q51037248

Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer.

Q51059520

A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire.

Q54268435

Genetic Testing for Women Previously Diagnosed with Breast/Ovarian Cancer: Examining the Impact of BRCA1 and BRCA2 Mutation Searching

Q57694666

The List of Threatening Experiences: the reliability and validity of a brief life events questionnaire

Q68918765

Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer

Q75306808

Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample

Q77476124

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

Q83917287

A role for common genomic variants in the assessment of familial breast cancer

Q85312916

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

491